Pfizer and Myocarditis
COVID-19, Pharma
September 29, 2021 - 11:50 am
In an article published here back in August 2021 titled “Barclays Global Healthcare Conference” we saw parts of a high-level discussion between two top Pfizer executives and a Senior Biopharma Analyst at Barclays Bank. The conversation revolved around being able to hike prices of “The Vaccine” at some point in the future, the “durability of […]